1. Home
  2. CHRO vs YYAI Comparison

CHRO vs YYAI Comparison

Compare CHRO & YYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHRO
  • YYAI
  • Stock Information
  • Founded
  • CHRO 2002
  • YYAI 2015
  • Country
  • CHRO United States
  • YYAI Hong Kong
  • Employees
  • CHRO N/A
  • YYAI N/A
  • Industry
  • CHRO
  • YYAI
  • Sector
  • CHRO
  • YYAI
  • Exchange
  • CHRO Nasdaq
  • YYAI NYSE
  • Market Cap
  • CHRO 11.3M
  • YYAI 12.1M
  • IPO Year
  • CHRO 2024
  • YYAI N/A
  • Fundamental
  • Price
  • CHRO $1.68
  • YYAI $0.64
  • Analyst Decision
  • CHRO Strong Buy
  • YYAI
  • Analyst Count
  • CHRO 1
  • YYAI 0
  • Target Price
  • CHRO N/A
  • YYAI N/A
  • AVG Volume (30 Days)
  • CHRO 104.9K
  • YYAI 1.7M
  • Earning Date
  • CHRO 03-04-2025
  • YYAI 03-04-2025
  • Dividend Yield
  • CHRO N/A
  • YYAI N/A
  • EPS Growth
  • CHRO N/A
  • YYAI N/A
  • EPS
  • CHRO N/A
  • YYAI N/A
  • Revenue
  • CHRO N/A
  • YYAI N/A
  • Revenue This Year
  • CHRO N/A
  • YYAI N/A
  • Revenue Next Year
  • CHRO N/A
  • YYAI N/A
  • P/E Ratio
  • CHRO N/A
  • YYAI N/A
  • Revenue Growth
  • CHRO N/A
  • YYAI N/A
  • 52 Week Low
  • CHRO $0.45
  • YYAI $0.35
  • 52 Week High
  • CHRO $4.84
  • YYAI $53.00
  • Technical
  • Relative Strength Index (RSI)
  • CHRO 50.49
  • YYAI 47.76
  • Support Level
  • CHRO $1.59
  • YYAI $0.35
  • Resistance Level
  • CHRO $1.99
  • YYAI $0.67
  • Average True Range (ATR)
  • CHRO 0.29
  • YYAI 0.07
  • MACD
  • CHRO -0.06
  • YYAI 0.07
  • Stochastic Oscillator
  • CHRO 41.44
  • YYAI 90.66

About CHRO Chromocell Therapeutics Corporation

Channel Therapeutics Corp is a clinical-stage biotechnology company developing and commercializing novel, non-opioid, non-addictive therapeutics to alleviate pain. The initial clinical focus is to selectively target the sodium ion channel known as NaV1.7 for the treatment of various types of chronic pain, acute and chronic eye pain, and post-surgical nerve blocks. Its pipeline includes CC8464 for ISFN and EM and CT2000 for Acute and CHronic Eye Pain-Dry Eye Disease.

About YYAI CONNEXA SPORTS TECHNOLOGIES IN

Connexa Sports Technologies Inc operates in the sports equipment and technology business. It is a connected sports company delivering products, technologies, and services across the Watch, Play, Learn commercial and subscription-as-a-service activities in sports. The company's offerings include Slinger Launcher, which is comprised of a portable tennis ball launcher, a portable padel tennis ball launcher, and a portable pickleball launcher. Through Gameface, it provides AI technology and performance analytics.

Share on Social Networks: